Abstract
Psoriatic arthritis (PA) is an inflammatory arthritis associated with cutaneous psoriasis. Treatment consists of non-steroidal anti-inflammatory drugs, corticosteroids at low doses and disease-modifying anti-rheumatic drugs. We relate a case of PA that after the fault of the handlings convecionais to sick we opted for an empiric treatment with Abatacept, based on the current knowledge on the physiopathology of PA and its low hepatotoxicity found in an animal model.
References
Fitzgerald O (2008) Psoriatic arthritis. In: Firestein GS, Budd RC, Harris ED Jr, McInnes IB, Ruddy S, Sergent JS (eds) Kelley’s textbook of rheumatology. Available via DIALOG. http://www.mdconsult.com/das/book/body/132831804-2/0/1807/528.html. Accessed 21 Apr 2009
Ritchlin C (2008) Psoriatic arthritis: pathology and pathogenesis. In: Klippel JH, Stone JH, Crofford LJ, White PH (eds) Primer on the rheumatic diseases. Springer Science, New York, pp 178–184
Jones G, Crotty M, Brooks P (2008) Intervenciones para el tratamiento de la artritis psoriásica (Cochrane Review). In: La Biblioteca Cochrane Plus, Issue 3. Available via DIALOG. http://www.update-software.com/abstractsES/AB000212-ES.htm. Accessed 21 Apr 2009
Nash P, Clegg DO (2005) Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Ann Rheum Dis 64(Suppl II):ii74–ii77. doi:10.1136/ard.2004.030783
Gartehner G, Hansen RA, Thieda P, Jonas B, Lohr KN, Carey T (2005) Drug class review on target immune modulators. Available via DIALOG. http://www.ohsu.edu/drugeffectiveness. Accessed 1 Dec 2008
Baker H, Ryan TJ (1968) Generalized pustular psoriasis: a clinical and epidemiological study of 104 cases. Br J Dermatol 80:771–793. doi:10.1111/j.1365-2133.1968.tb11947.x
Turkiewicz AM, Moreland LW (2007) Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options. Arthritis Rheum 56:1051–1066. doi:10.1002/art.22489
Kuek A, Hazleman BL, Ostör AJ (2007) Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 83(978):251–260. doi:10.1136/pgmj.2006.052688
Nakayama Y, Shimizu Y, Hirano K, Ebata K, Minemura M, Watanabe A, Sugiyama T (2005) CTLA-4Ig suppresses liver injury by inhibiting acquired immune responses in a mouse model of fulminant hepatitis. Hepatology 42(4):915–924. doi:10.1002/hep.20872
Westhovens R, Verschueren P (2008) Translating co-stimulation blockade into clinical practice. Arthritis Res Ther 10(Suppl 1):S4. doi:10.1186/ar2415
Conflicts of interest statement
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vieira, F.J.F., Callado, M.R.M. & Vieira, W.P. Abatacept as an option therapy in difficult to treat psoriatic arthritis. Rheumatol Int 30, 849–850 (2010). https://doi.org/10.1007/s00296-009-1041-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-1041-1